tirzepatide comprimido Microdose FDA says years-long tirzepatide shortage

Zepbound is Eli Lilly's brand name for tirzepatide - an injectable prescription medication FDA-approved for two indications: chronic weight management in adults with obesity (BMI 30) or in adults who are overweight (BMI 27) with at least one weight-related health condition, and treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity

It is that it needs unpacking

Reconstitution with bacteriostatic water creates an injectable solution

(This would apply to any of the six peptides discussed in the meeting.) Any clinics currently claiming the peptide is FDA approved or fully cleared for commercial human use are making legally false statements